You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Phase 1

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Breast Cancer Trial (CBD Oral, Control)

Not yet recruiting
  • Breast Cancer
  • CBD Oral
  • Control
  • (no location specified)
Nov 18, 2023

Healthy Participants Trial (PMN310, Placebo)

Not yet recruiting
  • Healthy Participants
  • (no location specified)
Oct 26, 2023

Cystic Fibrosis Trial (VX-828, Placebo, Itraconazole)

Not yet recruiting
  • Cystic Fibrosis
  • (no location specified)
Nov 23, 2023

Advanced Solid Tumor Trial (NXP900)

Not yet recruiting
  • Advanced Solid Tumor
  • (no location specified)
May 15, 2023

Healthy Trial (ABBV-CLS-7262)

Not yet recruiting
  • Healthy
  • (no location specified)
Nov 17, 2023

Cancer, Prostate Cancer, Metastatic Cancer Trial (177Lu-PSMA-I&T - escalating renal absorbed dose, 177Lu-PSMA-I&T - recommended

Not yet recruiting
  • Cancer
  • +3 more
  • 177Lu-PSMA-I&T - escalating renal absorbed dose
  • 177Lu-PSMA-I&T - recommended phase 2 regime
  • (no location specified)
Jun 14, 2023

Alpha-1 Antitrypsin Deficiency Trial (VX-668, Placebo)

Not yet recruiting
  • Alpha-1 Antitrypsin Deficiency
  • (no location specified)
Feb 3, 2023

Solid Tumor Trial in Birtinya (IBI130)

Not yet recruiting
  • Solid Tumor
  • Birtinya, Queensland, Australia
    Sunshine Coast University
Jun 19, 2023

Advanced Solid Tumors Trial (AMG 305)

Not yet recruiting
  • Advanced Solid Tumors
  • AMG 305
  • (no location specified)
Mar 24, 2023

Exocrine Pancreatic Insufficiency Trial in Ann Arbor (ANG003)

Recruiting
  • Exocrine Pancreatic Insufficiency
  • Ann Arbor, Michigan
    University of Michigan Medical Center
Sep 18, 2023

Adrenocortical Carcinoma Trial in Ann Arbor (68Ga-R8760 injection at pre-defined dose levels, 68GA-R8760 injection)

Recruiting
  • Adrenocortical Carcinoma
  • 68Ga-R8760 injection at pre-defined dose levels
  • 68GA-R8760 injection
  • Ann Arbor, Michigan
    University of Michigan Nuclear Medicine
Aug 11, 2023

Dyslipidemias, Familial Hypercholesterolemia, Hypertriglyceridemia Trial (VSA003, 0.9% NaCl)

Not yet recruiting
  • Dyslipidemias
  • +2 more
  • (no location specified)
May 9, 2023

Healthy Volunteers Trial in Melbourne (Verasone)

Not yet recruiting
  • Healthy Volunteers
  • Melbourne, Victoria, Australia
    Nucleus Network
Nov 19, 2023

Duchenne Muscular Dystrophy Trial in Garches (Phase 1, SQY51, Phase 2a, SQY51 (cohort 1), Phase 2a, SQY51 (cohort 2))

Recruiting
  • Duchenne Muscular Dystrophy
  • Phase 1, SQY51
  • +3 more
  • Garches, France
    Hôpital Raymond Poincaré
Mar 7, 2023

Ischemia-reperfusion Injury Trial in Adelaide (BX-001N Part 1, BX-001N Part 2, Placebo)

Not yet recruiting
  • Ischemia-reperfusion Injury
  • BX-001N Part 1
  • +2 more
  • Adelaide, South Australia, Australia
    CMAX Clinical Research
Oct 19, 2023

Corneal Edema, Corneal Endothelial Dysfunction Trial (AURN001)

Not yet recruiting
  • Corneal Edema
  • Corneal Endothelial Dysfunction
  • AURN001
  • (no location specified)
Sep 11, 2023

Non Small Cell Lung Cancer, Triple Negative Breast Cancer, Hodgkin Lymphoma Trial (CTX-8371)

Not yet recruiting
  • Non Small Cell Lung Cancer
  • +4 more
  • (no location specified)
Dec 4, 2023

Hypertension Trial in Madison (baxdrostat)

Completed
  • Hypertension
  • Madison, Wisconsin
    Labcorp Clinical Research Unit
Jul 18, 2023

Advanced Solid Tumor Trial in Boston (VAX014)

Not yet recruiting
  • Advanced Solid Tumor
  • Boston, Massachusetts
    Dana Farber Cancer Institute
Jun 2, 2023

Advanced Cancer Trial in South Brisbane, Bedford Park, Melbourne (AWT020)

Recruiting
  • Advanced Cancer
  • AWT020
  • South Brisbane, Queensland, Australia
  • +2 more
Oct 18, 2023

Duchenne Muscular Dystrophy Trial (NS-050/NCNP-03, Placebo)

Not yet recruiting
  • Duchenne Muscular Dystrophy
  • (no location specified)
Sep 19, 2023

Healthy Trial in Madison (Fadraciclib)

Active, not recruiting
  • Healthy
  • Madison, Wisconsin
    Labcorp Clinical Research Unit
Apr 5, 2023

Healthy Trial in Christchurch (LTG-001, Placebo)

Not yet recruiting
  • Healthy
  • Christchurch, New Zealand
    Clinical Research Unit
Sep 21, 2023

Prostate Cancer Trial (Lutetium Lu 177 JH020002 Injection)

Not yet recruiting
  • Prostate Cancer
  • Lutetium Lu 177 JH020002 Injection
  • (no location specified)
Nov 14, 2023

Solid Tumor, Adult, Metastatic Solid Tumor, Refractory Cancer Trial (ADU-1805, Pembrolizumab)

Not yet recruiting
  • Solid Tumor, Adult
  • +2 more
  • (no location specified)
May 3, 2023